Search
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 151 - 165 of 794 items.
ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting
AlertHealth professional risk communication | 2023-02-16
AG-BISOPROLOL: Foreign matter
RecallHealth product recall | 2023-02-14
Unauthorized products may pose serious health risks (June 16, 2022 to February 10, 2023)
AlertPublic advisory | 2023-02-10
Amitriptyline antidepressant drugs recalled because of a nitrosamine impurity
AlertPublic advisory | 2023-02-07
APO-AMITRIPTYLINE 10mg: NDMA Impurity
RecallHealth product recall | 2023-02-07
Celestone Soluspan: Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2023-01-31
RUZURGI (amifampridine) - Authorization Status
AlertHealth professional risk communication | 2023-01-20
Unauthorized health products removed from sale from More to Shoppe Facebook store and its Edson, Alberta, warehouse
AlertPublic advisory | 2023-01-20
Belzer MPS and Belzer UW: Particulate matter
RecallHealth product recall | 2023-01-18
99.0 % Oxygen USP - Gas cylinders containing commercial grade oxygen
RecallHealth product recall | 2022-12-22
NAT-Bendamustine: Discoloration
RecallHealth product recall | 2022-12-06
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Privigen: Series of adverse reactions
RecallHealth product recall | 2022-12-01
Teva-Atenolol; Product label image incorrect
RecallHealth product recall | 2022-11-21
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01